Monographs & Whitepapers
Immune Globulins: Therapeutic, Pharmaceutical, Cost, and Administration Considerations
With so many immune globulin products on the market, providers frequently have questions about the best approach to product selection. The charts in this updated review provide relevant information to help clinicians guide those decisions.
JUNE 26, 2025
Optimizing Care for Patients Requiring Parenteral Nutrition: Spotlight on Pediatrics
Strategies for improved parenteral nutrition administration have advanced significantly in the past few decades, and the FDA has approved new products with pediatric indications. In this Special Report, Debora Duro, MD, MS, reviews the available options as well as the published guidelines to assist clinicians in the safe and efficacious use of parenteral nutrition in pediatric patients.
MARCH 20, 2025
Emerging Data for Parenteral Nutrition Optimization in the ICU
During the 2024 Critical Care Congress of the Society of Critical Care Medicine, David C. Evans, MD, FACS, FCCM, FASPEN, and Sarah V. Cogle, PharmD, BCCCP, BCNSP, partnered to discuss lipid emulsions with clinician attendees. They reviewed current US lipid options; safety, compatibility, and stability information; clinical practice guidelines; lipid summit consensus statements; and the latest scientific studies. This Special Report reviews these important topics and how the emerging data may influence current clinical practice.
OCTOBER 3, 2024
Immune Globulins: Therapeutic, Pharmaceutical, Cost, and Administration Considerations
With so many immune globulin products on the market, providers frequently have questions about the best approach to product selection. The charts in this updated review provide relevant information to help clinicians guide those decisions.
APRIL 11, 2024
Immune Globulins: Therapeutic, Pharmaceutical, Cost, and Administration Considerations
With so many immune globulin products on the market, providers frequently have questions about the best approach to product selection. The charts in this updated review provide relevant information to help clinicians guide that decision.
MAY 9, 2023
Parenteral Nutrition Therapy: Assessment Tools and Guidelines
This pocket guide discusses nutritional assessment and requirements, parenteral nutrition (PN) formulation design, medication compatibility with PN, and guidelines for special diseases, as well as provides an overview of evidence-based guidelines and practices published by the American Society for Parenteral and Enteral Nutrition.
OCTOBER 12, 2022
Immune Globulins: Therapeutic, Pharmaceutical, Cost, and Administration Considerations
Having numerous immune globulin products on the market makes product selection challenging, and providers frequently have questions about the best approach to product selection. The tables in this wall chart provide relevant information to help clinicians guide that decision.
MAY 19, 2022
Immune Globulins: Therapeutic, Pharmaceutical, Cost, and Administration Considerations
Having numerous immune globulin products on the market makes product selection challenging, and providers frequently have questions about the best approach to product selection. The charts in this review provide relevant information to help clinicians guide that decision.
MARCH 8, 2022
Immune Globulins: Therapeutic, Pharmaceutical, Cost, and Administration Considerations
Having so many immune globulin (Ig) products on the market makes product selection more challenging, and providers frequently have questions about the best approach to product selection. The charts in this review should help pharmacists guide that decision.
APRIL 20, 2021
CUVITRU® [Immune Globulin Subcutaneous (Human)] 20% Solution for Primary Humoral Immunodeficiency Management: Clinical Case Studies and Review of Efficacy and Safety
This special report reviews the use of immune globulin replacement therapy CUVITRU in 3 case studies describing patients with primary humoral immunodeficiency (PI) of varying ages, lifestyles, and prevailing symptoms to illustrate the benefit of subcutaneous IG replacement therapy for the condition as well as an improved patient experience. Following the case studies, clinical efficacy and safety data for CUVITRU are presented, highlighting the utility of customizable subcutaneous IG for this patient population.
JULY 27, 2020
Use of Repatha® (evolocumab) For Treatment of High Cholesterol
This monograph describes the current treatment approach for lowering LDL-C, and characterizes Repatha® (evolocumab), a PCSK9 inhibitor antibody indicated in adults with established CVD, to reduce the risk of MI, stroke, and coronary revascularization, and as an adjunct to diet, alone or in combination with other lipid-lowering therapies (eg, statins, ezetimibe), for the treatment of adults with primary hyperlipidemia to reduce LDL-C.
OCTOBER 25, 2018
Primary Immunodeficiency
This monograph reviews the diagnosis of primary immunodeficiencies and focuses on management strategies that use intravenous and subcutaneous immunoglobulin (Ig) replacement products. As more product options have developed, the goals of Ig replacement therapy have expanded to include improved quality of life. Many strategies exist to maximize flexibility and individualization for patients receiving at-home therapy.
AUGUST 1, 2014
